CVRx® has developed a proprietary implantable technology designed for the treatment of heart failure and high blood pressure.
BAROSTIM NEO™ uses CVRx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. BAROSTIM NEO™ can be adjusted to meet each patient’s individual therapy needs.
A small device with a powerful effect
BAROSTIM THERAPY™ is effectively administered through BAROSTIM NEO™, a minimally-invasive, long-lasting device.
Subcutaneous, implantable system:
Carotid Sinus Lead:
A 2mm electrode is attached to the carotid artery and connected to the IPG, with the design to electrically activate the baroreceptors.
Implantable Pulse Generator (IPG) Device:
An implantable pulse generator is inserted under the skin, below the collar bone, delivering an electrical stimulation through the lead.
Wireless Programmer System:
A programmer system enables the clinician to customize therapy to the patients’ needs. The unique on/off capability can promote the observation of the differences that BAROSTIM THERAPY™ makes in blood pressure and other hemodynamic parameters.
For more information, please visit www.BAROSTIMTHERAPY.com